Acute myeloid leukemia: Difference between revisions

Jump to navigation Jump to search
Carlos Lopez (talk | contribs)
Carlos Lopez (talk | contribs)
Line 41: Line 41:


==Treatment==
==Treatment==
[[Acute myeloid leukemia medical therapy|Medical Therapy]] | [[Acute myeloid leukemia Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]] | [[Acute myeloid leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute myeloid leukemia future or investigational therapies|Future or Investigational Therapies]]
[[Acute myeloid leukemia medical therapy|Medical Therapy]] |[[Acute myeloid leukemia surgery|Surgery]]| [[Acute myeloid leukemia Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]] | [[Acute myeloid leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute myeloid leukemia future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==

Revision as of 18:24, 1 September 2015

Template:DiseaseDisorder infobox

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia

CDC on Acute myeloid leukemia

Acute myeloid leukemia in the news

Blogs on Acute myeloid leukemia

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3]

Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia; acute nonlymphocytic leukemia

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Myeloid Leukemia from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Diagnostic Studies

Treatment

Medical Therapy |Surgery| Chemotherapy | Relapsed AML | Supportive Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

External links

Template:Blood


Template:WikiDoc Sources